Katrin Männik1, Reedik Mägi2, Aurélien Macé3, Ben Cole4, Anna L Guyatt5, Hashem A Shihab6, Anne M Maillard7, Helene Alavere2, Anneli Kolk8, Anu Reigo2, Evelin Mihailov2, Liis Leitsalu9, Anne-Maud Ferreira10, Margit Nõukas9, Alexander Teumer11, Erika Salvi12, Daniele Cusi13, Matt McGue14, William G Iacono14, Tom R Gaunt6, Jacques S Beckmann15, Sébastien Jacquemont7, Zoltán Kutalik16, Nathan Pankratz4, Nicholas Timpson6, Andres Metspalu9, Alexandre Reymond17. 1. Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland2Estonian Genome Center, University of Tartu, Tartu. 2. Estonian Genome Center, University of Tartu, Tartu. 3. Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland4Swiss Institute of Bioinformatics, Lausanne, Switzerland. 4. Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis. 5. Bristol Genetic Epidemiology Laboratories, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom. 6. Bristol Genetic Epidemiology Laboratories, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom7MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom. 7. Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland. 8. Estonian Genome Center, University of Tartu, Tartu8Department of Neurology and Neurorehabilitation, Children's Clinic, Tartu University Hospital, Tartu, Estonia. 9. Estonian Genome Center, University of Tartu, Tartu9Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia. 10. Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland4Swiss Institute of Bioinformatics, Lausanne, Switzerland. 11. Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany. 12. Deparment of Health Sciences, University of Milan, Milan, Italy. 13. Deparment of Health Sciences, University of Milan, Milan, Italy12Institute of Biomedical Technologies, Italian National Research Council, Milan, Italy. 14. Department of Psychology, University of Minnesota, Minneapolis. 15. Swiss Institute of Bioinformatics, Lausanne, Switzerland. 16. Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland4Swiss Institute of Bioinformatics, Lausanne, Switzerland14Institute of Social and Preventive Medicine, Lausanne University Hospital (CHUV), Lausanne, Switzerland. 17. Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
Abstract
IMPORTANCE: The association of copy number variations (CNVs), differing numbers of copies of genetic sequence at locations in the genome, with phenotypes such as intellectual disability has been almost exclusively evaluated using clinically ascertained cohorts. The contribution of these genetic variants to cognitive phenotypes in the general population remains unclear. OBJECTIVE: To investigate the clinical features conferred by CNVs associated with known syndromes in adult carriers without clinical preselection and to assess the genome-wide consequences of rare CNVs (frequency ≤0.05%; size ≥250 kilobase pairs [kb]) on carriers' educational attainment and intellectual disability prevalence in the general population. DESIGN, SETTING, AND PARTICIPANTS: The population biobank of Estonia contains 52,000 participants enrolled from 2002 through 2010. General practitioners examined participants and filled out a questionnaire of health- and lifestyle-related questions, as well as reported diagnoses. Copy number variant analysis was conducted on a random sample of 7877 individuals and genotype-phenotype associations with education and disease traits were evaluated. Our results were replicated on a high-functioning group of 993 Estonians and 3 geographically distinct populations in the United Kingdom, the United States, and Italy. MAIN OUTCOMES AND MEASURES: Phenotypes of genomic disorders in the general population, prevalence of autosomal CNVs, and association of these variants with educational attainment (from less than primary school through scientific degree) and prevalence of intellectual disability. RESULTS: Of the 7877 in the Estonian cohort, we identified 56 carriers of CNVs associated with known syndromes. Their phenotypes, including cognitive and psychiatric problems, epilepsy, neuropathies, obesity, and congenital malformations are similar to those described for carriers of identical rearrangements ascertained in clinical cohorts. A genome-wide evaluation of rare autosomal CNVs (frequency, ≤0.05%; ≥250 kb) identified 831 carriers (10.5%) of the screened general population. Eleven of 216 (5.1%) carriers of a deletion of at least 250 kb (odds ratio [OR], 3.16; 95% CI, 1.51-5.98; P = 1.5e-03) and 6 of 102 (5.9%) carriers of a duplication of at least 1 Mb (OR, 3.67; 95% CI, 1.29-8.54; P = .008) had an intellectual disability compared with 114 of 6819 (1.7%) in the Estonian cohort. The mean education attainment was 3.81 (P = 1.06e-04) among 248 (≥250 kb) deletion carriers and 3.69 (P = 5.024e-05) among 115 duplication carriers (≥1 Mb). Of the deletion carriers, 33.5% did not graduate from high school (OR, 1.48; 95% CI, 1.12-1.95; P = .005) and 39.1% of duplication carriers did not graduate high school (OR, 1.89; 95% CI, 1.27-2.8; P = 1.6e-03). Evidence for an association between rare CNVs and lower educational attainment was supported by analyses of cohorts of adults from Italy and the United States and adolescents from the United Kingdom. CONCLUSIONS AND RELEVANCE: Known pathogenic CNVs in unselected, but assumed to be healthy, adult populations may be associated with unrecognized clinical sequelae. Additionally, individually rare but collectively common intermediate-size CNVs may be negatively associated with educational attainment. Replication of these findings in additional population groups is warranted given the potential implications of this observation for genomics research, clinical care, and public health.
IMPORTANCE: The association of copy number variations (CNVs), differing numbers of copies of genetic sequence at locations in the genome, with phenotypes such as intellectual disability has been almost exclusively evaluated using clinically ascertained cohorts. The contribution of these genetic variants to cognitive phenotypes in the general population remains unclear. OBJECTIVE: To investigate the clinical features conferred by CNVs associated with known syndromes in adult carriers without clinical preselection and to assess the genome-wide consequences of rare CNVs (frequency ≤0.05%; size ≥250 kilobase pairs [kb]) on carriers' educational attainment and intellectual disability prevalence in the general population. DESIGN, SETTING, AND PARTICIPANTS: The population biobank of Estonia contains 52,000 participants enrolled from 2002 through 2010. General practitioners examined participants and filled out a questionnaire of health- and lifestyle-related questions, as well as reported diagnoses. Copy number variant analysis was conducted on a random sample of 7877 individuals and genotype-phenotype associations with education and disease traits were evaluated. Our results were replicated on a high-functioning group of 993 Estonians and 3 geographically distinct populations in the United Kingdom, the United States, and Italy. MAIN OUTCOMES AND MEASURES: Phenotypes of genomic disorders in the general population, prevalence of autosomal CNVs, and association of these variants with educational attainment (from less than primary school through scientific degree) and prevalence of intellectual disability. RESULTS: Of the 7877 in the Estonian cohort, we identified 56 carriers of CNVs associated with known syndromes. Their phenotypes, including cognitive and psychiatric problems, epilepsy, neuropathies, obesity, and congenital malformations are similar to those described for carriers of identical rearrangements ascertained in clinical cohorts. A genome-wide evaluation of rare autosomal CNVs (frequency, ≤0.05%; ≥250 kb) identified 831 carriers (10.5%) of the screened general population. Eleven of 216 (5.1%) carriers of a deletion of at least 250 kb (odds ratio [OR], 3.16; 95% CI, 1.51-5.98; P = 1.5e-03) and 6 of 102 (5.9%) carriers of a duplication of at least 1 Mb (OR, 3.67; 95% CI, 1.29-8.54; P = .008) had an intellectual disability compared with 114 of 6819 (1.7%) in the Estonian cohort. The mean education attainment was 3.81 (P = 1.06e-04) among 248 (≥250 kb) deletion carriers and 3.69 (P = 5.024e-05) among 115 duplication carriers (≥1 Mb). Of the deletion carriers, 33.5% did not graduate from high school (OR, 1.48; 95% CI, 1.12-1.95; P = .005) and 39.1% of duplication carriers did not graduate high school (OR, 1.89; 95% CI, 1.27-2.8; P = 1.6e-03). Evidence for an association between rare CNVs and lower educational attainment was supported by analyses of cohorts of adults from Italy and the United States and adolescents from the United Kingdom. CONCLUSIONS AND RELEVANCE: Known pathogenic CNVs in unselected, but assumed to be healthy, adult populations may be associated with unrecognized clinical sequelae. Additionally, individually rare but collectively common intermediate-size CNVs may be negatively associated with educational attainment. Replication of these findings in additional population groups is warranted given the potential implications of this observation for genomics research, clinical care, and public health.
Authors: Charlotte N Henrichsen; Nicolas Vinckenbosch; Sebastian Zöllner; Evelyne Chaignat; Sylvain Pradervand; Frédéric Schütz; Manuel Ruedi; Henrik Kaessmann; Alexandre Reymond Journal: Nat Genet Date: 2009-03-08 Impact factor: 38.330
Authors: Marwan Shinawi; Pengfei Liu; Sung-Hae L Kang; Joseph Shen; John W Belmont; Daryl A Scott; Frank J Probst; William J Craigen; Brett H Graham; Amber Pursley; Gary Clark; Jennifer Lee; Monica Proud; Amber Stocco; Diana L Rodriguez; Beth A Kozel; Steven Sparagana; Elizabeth R Roeder; Susan G McGrew; Thaddeus W Kurczynski; Leslie J Allison; Stephen Amato; Sarah Savage; Ankita Patel; Pawel Stankiewicz; Arthur L Beaudet; Sau Wai Cheung; James R Lupski Journal: J Med Genet Date: 2009-11-12 Impact factor: 6.318
Authors: Erika Salvi; Zoltán Kutalik; Nicola Glorioso; Paola Benaglio; Francesca Frau; Tatiana Kuznetsova; Hisatomi Arima; Clive Hoggart; Jean Tichet; Yury P Nikitin; Costanza Conti; Jitka Seidlerova; Valérie Tikhonoff; Katarzyna Stolarz-Skrzypek; Toby Johnson; Nabila Devos; Laura Zagato; Simonetta Guarrera; Roberta Zaninello; Andrea Calabria; Benedetta Stancanelli; Chiara Troffa; Lutgarde Thijs; Federica Rizzi; Galina Simonova; Sara Lupoli; Giuseppe Argiolas; Daniele Braga; Maria C D'Alessio; Maria F Ortu; Fulvio Ricceri; Maurizio Mercurio; Patrick Descombes; Maurizio Marconi; John Chalmers; Stephen Harrap; Jan Filipovsky; Murielle Bochud; Licia Iacoviello; Justine Ellis; Alice V Stanton; Maris Laan; Sandosh Padmanabhan; Anna F Dominiczak; Nilesh J Samani; Olle Melander; Xavier Jeunemaitre; Paolo Manunta; Amnon Shabo; Paolo Vineis; Francesco P Cappuccio; Mark J Caulfield; Giuseppe Matullo; Carlo Rivolta; Patricia B Munroe; Cristina Barlassina; Jan A Staessen; Jacques S Beckmann; Daniele Cusi Journal: Hypertension Date: 2011-12-19 Impact factor: 10.190
Authors: Andy Boyd; Jean Golding; John Macleod; Debbie A Lawlor; Abigail Fraser; John Henderson; Lynn Molloy; Andy Ness; Susan Ring; George Davey Smith Journal: Int J Epidemiol Date: 2012-04-16 Impact factor: 7.196
Authors: Christelle Golzio; Jason Willer; Michael E Talkowski; Edwin C Oh; Yu Taniguchi; Sébastien Jacquemont; Alexandre Reymond; Mei Sun; Akira Sawa; James F Gusella; Atsushi Kamiya; Jacques S Beckmann; Nicholas Katsanis Journal: Nature Date: 2012-05-16 Impact factor: 49.962
Authors: G Davies; N Armstrong; J C Bis; J Bressler; V Chouraki; S Giddaluru; E Hofer; C A Ibrahim-Verbaas; M Kirin; J Lahti; S J van der Lee; S Le Hellard; T Liu; R E Marioni; C Oldmeadow; I Postmus; A V Smith; J A Smith; A Thalamuthu; R Thomson; V Vitart; J Wang; L Yu; L Zgaga; W Zhao; R Boxall; S E Harris; W D Hill; D C Liewald; M Luciano; H Adams; D Ames; N Amin; P Amouyel; A A Assareh; R Au; J T Becker; A Beiser; C Berr; L Bertram; E Boerwinkle; B M Buckley; H Campbell; J Corley; P L De Jager; C Dufouil; J G Eriksson; T Espeseth; J D Faul; I Ford; R F Gottesman; M E Griswold; V Gudnason; T B Harris; G Heiss; A Hofman; E G Holliday; J Huffman; S L R Kardia; N Kochan; D S Knopman; J B Kwok; J-C Lambert; T Lee; G Li; S-C Li; M Loitfelder; O L Lopez; A J Lundervold; A Lundqvist; K A Mather; S S Mirza; L Nyberg; B A Oostra; A Palotie; G Papenberg; A Pattie; K Petrovic; O Polasek; B M Psaty; P Redmond; S Reppermund; J I Rotter; H Schmidt; M Schuur; P W Schofield; R J Scott; V M Steen; D J Stott; J C van Swieten; K D Taylor; J Trollor; S Trompet; A G Uitterlinden; G Weinstein; E Widen; B G Windham; J W Jukema; A F Wright; M J Wright; Q Yang; H Amieva; J R Attia; D A Bennett; H Brodaty; A J M de Craen; C Hayward; M A Ikram; U Lindenberger; L-G Nilsson; D J Porteous; K Räikkönen; I Reinvang; I Rudan; P S Sachdev; R Schmidt; P R Schofield; V Srikanth; J M Starr; S T Turner; D R Weir; J F Wilson; C van Duijn; L Launer; A L Fitzpatrick; S Seshadri; T H Mosley; I J Deary Journal: Mol Psychiatry Date: 2015-02-03 Impact factor: 15.992
Authors: Shane E McCarthy; Vladimir Makarov; George Kirov; Anjene M Addington; Jon McClellan; Seungtai Yoon; Diana O Perkins; Diane E Dickel; Mary Kusenda; Olga Krastoshevsky; Verena Krause; Ravinesh A Kumar; Detelina Grozeva; Dheeraj Malhotra; Tom Walsh; Elaine H Zackai; Paige Kaplan; Jaya Ganesh; Ian D Krantz; Nancy B Spinner; Patricia Roccanova; Abhishek Bhandari; Kevin Pavon; B Lakshmi; Anthony Leotta; Jude Kendall; Yoon-Ha Lee; Vladimir Vacic; Sydney Gary; Lilia M Iakoucheva; Timothy J Crow; Susan L Christian; Jeffrey A Lieberman; T Scott Stroup; Terho Lehtimäki; Kaija Puura; Chad Haldeman-Englert; Justin Pearl; Meredith Goodell; Virginia L Willour; Pamela Derosse; Jo Steele; Layla Kassem; Jessica Wolff; Nisha Chitkara; Francis J McMahon; Anil K Malhotra; James B Potash; Thomas G Schulze; Markus M Nöthen; Sven Cichon; Marcella Rietschel; Ellen Leibenluft; Vlad Kustanovich; Clara M Lajonchere; James S Sutcliffe; David Skuse; Michael Gill; Louise Gallagher; Nancy R Mendell; Nick Craddock; Michael J Owen; Michael C O'Donovan; Tamim H Shaikh; Ezra Susser; Lynn E Delisi; Patrick F Sullivan; Curtis K Deutsch; Judith Rapoport; Deborah L Levy; Mary-Claire King; Jonathan Sebat Journal: Nat Genet Date: 2009-10-25 Impact factor: 38.330
Authors: Andrew T M Bagshaw; L John Horwood; Youfang Liu; David M Fergusson; Patrick F Sullivan; Martin A Kennedy Journal: PLoS One Date: 2013-01-30 Impact factor: 3.240
Authors: S Anazi; S Maddirevula; E Faqeih; H Alsedairy; F Alzahrani; H E Shamseldin; N Patel; M Hashem; N Ibrahim; F Abdulwahab; N Ewida; H S Alsaif; H Al Sharif; W Alamoudi; A Kentab; F A Bashiri; M Alnaser; A H AlWadei; M Alfadhel; W Eyaid; A Hashem; A Al Asmari; M M Saleh; A AlSaman; K A Alhasan; M Alsughayir; M Al Shammari; A Mahmoud; Z N Al-Hassnan; M Al-Husain; R Osama Khalil; N Abd El Meguid; A Masri; R Ali; T Ben-Omran; P El Fishway; A Hashish; A Ercan Sencicek; M State; A M Alazami; M A Salih; N Altassan; S T Arold; M Abouelhoda; S M Wakil; D Monies; R Shaheen; F S Alkuraya Journal: Mol Psychiatry Date: 2016-07-19 Impact factor: 15.992
Authors: Ryan K C Yuen; Daniele Merico; Matt Bookman; Jennifer L Howe; Bhooma Thiruvahindrapuram; Rohan V Patel; Joe Whitney; Nicole Deflaux; Jonathan Bingham; Zhuozhi Wang; Giovanna Pellecchia; Janet A Buchanan; Susan Walker; Christian R Marshall; Mohammed Uddin; Mehdi Zarrei; Eric Deneault; Lia D'Abate; Ada J S Chan; Stephanie Koyanagi; Tara Paton; Sergio L Pereira; Ny Hoang; Worrawat Engchuan; Edward J Higginbotham; Karen Ho; Sylvia Lamoureux; Weili Li; Jeffrey R MacDonald; Thomas Nalpathamkalam; Wilson W L Sung; Fiona J Tsoi; John Wei; Lizhen Xu; Anne-Marie Tasse; Emily Kirby; William Van Etten; Simon Twigger; Wendy Roberts; Irene Drmic; Sanne Jilderda; Bonnie MacKinnon Modi; Barbara Kellam; Michael Szego; Cheryl Cytrynbaum; Rosanna Weksberg; Lonnie Zwaigenbaum; Marc Woodbury-Smith; Jessica Brian; Lili Senman; Alana Iaboni; Krissy Doyle-Thomas; Ann Thompson; Christina Chrysler; Jonathan Leef; Tal Savion-Lemieux; Isabel M Smith; Xudong Liu; Rob Nicolson; Vicki Seifer; Angie Fedele; Edwin H Cook; Stephen Dager; Annette Estes; Louise Gallagher; Beth A Malow; Jeremy R Parr; Sarah J Spence; Jacob Vorstman; Brendan J Frey; James T Robinson; Lisa J Strug; Bridget A Fernandez; Mayada Elsabbagh; Melissa T Carter; Joachim Hallmayer; Bartha M Knoppers; Evdokia Anagnostou; Peter Szatmari; Robert H Ring; David Glazer; Mathew T Pletcher; Stephen W Scherer Journal: Nat Neurosci Date: 2017-03-06 Impact factor: 24.884
Authors: Michael H Guo; Satish K Nandakumar; Jacob C Ulirsch; Seyedeh M Zekavat; Jason D Buenrostro; Pradeep Natarajan; Rany M Salem; Roberto Chiarle; Mario Mitt; Mart Kals; Kalle Pärn; Krista Fischer; Lili Milani; Reedik Mägi; Priit Palta; Stacey B Gabriel; Andres Metspalu; Eric S Lander; Sekar Kathiresan; Joel N Hirschhorn; Tõnu Esko; Vijay G Sankaran Journal: Proc Natl Acad Sci U S A Date: 2016-12-28 Impact factor: 11.205
Authors: Madelyn A Gillentine; Ricardo Lozoya; Jiani Yin; Christopher M Grochowski; Janson J White; Christian P Schaaf; Chadi A Calarge Journal: J Affect Disord Date: 2018-07-11 Impact factor: 4.839
Authors: Miguel Verbitsky; Amy J Kogon; Matthew Matheson; Stephen R Hooper; Craig S Wong; Bradley A Warady; Susan L Furth; Ali G Gharavi Journal: J Am Soc Nephrol Date: 2017-03-27 Impact factor: 10.121
Authors: James R Lupski; Pengfei Liu; Pawel Stankiewicz; Claudia M B Carvalho; Jennifer E Posey Journal: Expert Rev Mol Diagn Date: 2020-10-10 Impact factor: 5.225